Krassikova LS, Karshieva SS, Cheglakov IB, Belyavsky AV. Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition. The Journal of Gene Medicine. 2016 Sep;18(9):220–33. doi: 10.1002/jgm.2894.
Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition